FRGG
Asset Logo

Franklin Global Growth Fund (Managed Fund)

๐Ÿ‡ฆ๐Ÿ‡บ ASX

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ“™ Holdings

๐Ÿ’ฐ Distributions

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

+ 14.40%
Growth

8 months growth

๐Ÿ’ฐ

5.22%
Annual distribution yield

Based on the most recent distribution

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

0
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

FRGG.AX was created on 2024-04-15 by Franklin. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to outperform the MSCI World ex Australia Index NR, in Australian dollar terms after fees and expenses (but before taxes), over the medium to longer term.

๐ŸŒ Website

๐Ÿ“ˆ Performance

Price History

+9.17%

1M

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ“™ Top Holdings

Show more

Top holdings information is not yet available for this fund. For more information please visit the fund manager's website.

๐Ÿ’ฐ Distributions

Payouts

๐Ÿ’ฐ Annual Distribution Yield*

5.22%

๐Ÿ’ฐ Annual Distribution Earnings Per $1,000 invested**

$52.19

๐Ÿ’ฐ Most Recent Distribution Franked Percentage Estimate

0.00%

๐Ÿ’ฐ Average Distribution Franked Percentage Estimate

0.00 %

๐Ÿ’ฐ Distribution reinvestment

Learn more

* Based on the most recent distribution

** Calculated by multiplying the most recent distribution yield by $1,000

Estimate your distribution

If you held

$

of FRGG, your last distribution payment(s) would have been:

$ 521.88

on Fri Jul 12 2024

*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.

Distribution History

1Y

5Y

10Y

Graph

Table

Year
Yearly Distribution Earnings Per Share
Franking Estimate

2024

$0.12

0.00%

2023

$0.00

0.00%

2022

$0.00

0.00%

2021

$0.00

0.00%

2020

$0.00

0.00%

2019

$0.00

0.00%

2018

$0.00

0.00%

2017

$0.00

0.00%

2016

$0.00

0.00%

2015

$0.00

0.00%

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

0.90%
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$2.62

๐Ÿ’ฐ Price To Earnings Ratio

0.00

๐Ÿ’ฐ Price To Book Ratio

0.00

๐Ÿ’ฐ Leveraged

No

๐Ÿ’ฐ Inverse

No

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in FRGG

0

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

N/A

๐Ÿ’ต Average investment amount

N/A

โฐ Last time a customer invested in FRGG

N/A
FRGG investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

๐Ÿ™‹ Legal gender of investors

Female

Male

Pearlers who invest in FRGG also invest in...

Want more shares? Try these...

Finbar Group Limited

FRI

Finbar Group Ltd. engages in the development of medium to high density residential apartments and commercial property. The company is headquartered in Perth, Western Australia. The firm is focused on the development of medium to high-density residential buildings and commercial developments in Western Australia by way of direct ownership, ownership through fully owned subsidiaries or by equity accounted investees. Its segments include Residential Apartment Development, Commercial Office/Retail development, and Rental of Property. Its segments are all located in West Australia. The Companyโ€™s completed projects include AT238, Vue Tower, One Kennedy, Dianella Apartments and REVA. Its under construction projects include Civic Heart, Aurora Applecross and The Point. The firm holds its rental properties through 175 Adelaide Terrace Pty Ltd, 31 Rowe Avenue Pty Ltd, 32 Riversdale Road Pty Ltd, 36 Chester Avenue Pty Ltd, 43 McGregor Road Pty Ltd, 5-7 Harper Terrace Pty Ltd, Finbar Karratha Pty Ltd and Finbar Commercial Pty Ltd.

๐Ÿ™Œ Performance (5Yr p.a)

-1.29%

๐Ÿ“Š Share price

$0.80 AUD

๐Ÿ’ฐ HIGH DIVIDEND

๐Ÿ  REAL ESTATE

Find Out More

Farm Pride Foods Ltd. engages in the provision of consumer goods, which includes the production, processing, and selling of egg and egg related products such as egg white, egg yolk, scrambled egg, fried eggs, crepes. The company is headquartered in Melbourne, Victoria. The firm farms, processes and markets a range of egg and egg-related products. The firm develops its farming business to meet the requirement for cage-free eggs. The company maintains relationships in the supermarket channel and with industrial food manufacturers. Along with its range of fresh eggs, found in supermarkets across the eastern seaboard, the Company also manufactures egg products at its Keysborough Processing Plant. The company supplies all commercial markets, including the airline, hotel and restaurant industries among others, with its range of egg products. The firm manufactures its own egg cartons using recycled newsprint and cardboard. The firm offers egg products, such as whole eggs, egg white, egg yolk, scrambled eggs, peeled boiled eggs, fried eggs, omelets and egg cartoons. The firm sources its fresh eggs from its own farms and local suppliers across the country.

๐Ÿ™Œ Performance (5Yr p.a)

-10.33%

๐Ÿ“Š Share price

$0.12 AUD

๐Ÿ” FOOD PRODUCTS

Firebird Metals Ltd. engages in the exploration and development of mineral properties. The firm is focused on combining mining and downstream processing for the advancement of the electric vehicle (EV) battery sector. Its projects include Oakover Manganese Project, Wandanya Project and Hill 616 Manganese Project. The Oakover Manganese Project is located approximately 85 kilometers (kms) east of Newman in the Eastern Pilbara region of Western Australia and about 100 kms south of the Ant Hill manganese deposit and about 50 kms from the Nicholas Downs manganese deposit. The Hill 616 Manganese Project is located over 85 kms southeast of Newman within the Peak Hill Mineral Field. Wandanya Project consists of two exploration license applications E46/1456 and E46/1457, which cover an area of 51 square kilometers (Km2) located in the Eastern Pilbara Region of Western Australia. Its other projects include Disraeli Manganese Project, Midgengadge Manganese Project and Raggard Hills Manganese Project.

๐Ÿ“Š Share price

$0.11 AUD

โ›๏ธ MINING

Firebrick Pharma Ltd. is a pharmaceutical company, which engages in the development and commercialization of nasal spray treatment for the common cold based around the potential of povidone-iodine as an antimicrobial agent. The company is headquartered in Melbourne, Victoria. The company went IPO on 2022-01-28. The principal activity for the Company is the clinical development and partnering of Nasodine, a broad-spectrum antimicrobial spray for the treatment of the common cold. The firm has developed a povidone-iodine nasal spray, called Nasodine Nasal Spray and filed international trademarks and multiple patents on the product, including a formulation patent and two use patents, some of which have already been granted in the United States, Europe and Australia. The firm has also completed six clinical trials for Nasodine, including a Phase I study, three Phase II studies and two Phase III studies, which have affirmed the productโ€™s safety and generally supported its efficacy as an antimicrobial nasal spray with utility in a range of clinical settings. Nasodine Phase II COVID-19 trail achieves primarily endpoints.

๐Ÿ“Š Share price

$0.05 AUD

๐Ÿ“ฆ LOGISTICS

Compare
Add to watchlist